High Tower Advisors, LLC Dexcom Inc Call Options Transaction History

High Tower Advisors, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 11, 2023	BUY	$104.0 - $122.92 $52,000 - $61,460	500 New	500 $58,000
Q3 2020 Nov 13, 2020	SELL	$95.51 - $112.95 $19,102 - $22,590	-200 Reduced 66.67%	100 $5,000
Q1 2019 May 15, 2019	SELL	$28.07 - $38.18 $19,649 - $26,726	-700 Reduced 70.0%	300 $0
Q2 2018 Aug 14, 2018	BUY	$17.54 - $25.22 $17,540 - $25,220	1,000 New	1,000 $2,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.